You have been successfully added to our newsletter.
Let our news meet your inbox
Emotional debate marks FDA hearing on Avastin
Breast cancer survivors and doctors make heated arguments in front of the FDA as the panel decides the fate of Avastin - a breast cancer drug that costs $88 thousand a year for treatment. NBC's Robert Bazell.Jun.28.2011